Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions

AIDS
J Martinez-PicadoL Ruiz

Abstract

A new HIV-1 treatment strategy based on repeated structured treatment interruptions (STI) is currently being evaluated in clinical trials to determine whether immune cell-mediated control of viral replication can be stimulated by intermittent periods of viral replication. The potential for selection of drug-resistant quasi-species remains a major concern of such a treatment strategy. Plasma and peripheral blood lymphocyte (PBL) samples from 12 patients who had three consecutive STIs were studied. Genotypic analysis was based on population and clonal sequencing. Drug susceptibility and their corresponding replication capacities were evaluated by a single-cycle growth assay. Consistent with a loss of phenotypic susceptibility to lamivudine, the M184V mutation was detected by genotypic analysis (direct and clonal sequencing) in plasma samples collected from two patients at the end of the second or third STI. Longitudinal analysis of patient samples revealed a step-wise increase in the M184V mutation in each patient virus population over successive STIs, despite the lower replicative capacity associated with this mutation in the absence of antiviral agents. Drug-resistant virus can rise to high frequencies in chronically HIV-1 infe...Continue Reading

References

Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·R T DaveyH C Lane
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·C J PetropoulosJ M Whitcomb
Nov 9, 2000·Journal of Virology·A F MaréeR J De Boer
Oct 16, 2001·AIDS·F R SattlerM P Dube

❮ Previous
Next ❯

Citations

Jan 6, 2007·Journal of Mathematical Biology·O Krakovska, L M Wahl
Mar 17, 2004·Current Infectious Disease Reports·Jason D. Barbour, Robert M. Grant
Aug 6, 2004·Bulletin of Mathematical Biology·Seema H BajariaDenise E Kirschner
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin S HirschDouglas D Richman
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julia G PradoJavier Martinez-Picado
Aug 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M Arnedo-ValeroJ M Gatell
Jul 24, 2010·The Journal of Infectious Diseases·Sara Gianella, Douglas D Richman
Jan 2, 2007·AIDS·Jintanat Ananworanich, Bernard Hirschel
Feb 16, 2007·AIDS·Bruno MarchouUNKNOWN ANRS 106 Study team
Jan 26, 2008·HIV Medicine·S LouvelUNKNOWN Swiss HIV Cohort Study
Mar 9, 2004·Journal of Clinical Microbiology·Manzour Hernando Hazbón, David Alland
May 31, 2011·Biomedical Engineering Online·Ryan Zurakowski
Aug 23, 2003·American Journal of Clinical Pathology·Estelle M Piwowar-ManningJ Brooks Jackson
Jan 5, 2005·PLoS Medicine·Emmanouil PapasavvasLuis J Montaner
Apr 25, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Mary A VoglerVictoria A Johnson
Feb 17, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Roberto Arduino
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ume L Abbas, John W Mellors
Apr 18, 2003·AIDS·Steven G Deeks, Bernard Hirschel
Aug 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Juan Luis Gûmez SirventMarìa Remedios Aleman Valls
May 28, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Adele L McCormickUNKNOWN DART Virology Group and Trial Team
Jan 1, 2007·Current Opinion in HIV and AIDS·Javier Martinez-Picado, Lily Wai Yan Tam
Oct 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Salvador ResinoM Angeles Muñoz-Fernández
Mar 11, 2005·Expert Review of Anti-infective Therapy·Jintanat Ananworanich, Bernard Hirschel
Oct 16, 2004·Expert Review of Anti-infective Therapy·Annette Oxenius, Bernard Hirschel
May 31, 2002·Expert Opinion on Pharmacotherapy·Jean-Jacques Parienti
Mar 10, 2004·Expert Opinion on Biological Therapy·Maja A SommerfeltBirger Sørensen
Jul 19, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Alessandra AmendolaMaria Rosaria Capobianchi
Oct 8, 2009·Antiviral Research·Roger Paredes, Bonaventura Clotet
Dec 24, 2005·Enfermedades infecciosas y microbiología clínica·Felipe GarcíaPere Domingo
Feb 22, 2008·Virus Research·Javier Martinez-Picado, Miguel Angel Martínez
Sep 15, 2011·Journal of Medical Virology·Milosz ParczewskiAnna Boron-Kaczmarska
Jan 23, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Gerond Lake-Bakaar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.